Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
May 5, 2017
Alcobra Provides Update on Cancellation of Extraordinary Meeting Called by Brosh Group
TEL AVIV, Israel, May 05, 2017 (GLOBE NEWSWIRE) -- Alcobra Ltd. (ADHD), an emerging pharmaceutical company focused on the development of new medications to treat ...
May 5, 2017
Achaogen Receives Investment from the Bill & Melinda Gates Foundation to Develop Antibodies Against Gram-Negative Bacteria
SOUTH SAN FRANCISCO, Calif., May 05, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing novel antibacterials addressing multidrug-resistant (MDR) gram-negative infections, ...
May 5, 2017
First-Ever European Analysis of Electronic Brachytherapy Using the Xoft System for Endometrial and Cervical Cancer Treatment to be Presented at European Society for Radiotherapy & Oncology Meeting
NASHUA, N.H. and VIENNA, Austria, May 05, 2017 (GLOBE NEWSWIRE) -- (Booth #4330) - iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and ...
May 5, 2017
Rockwell Medical Schedules First Quarter 2017 Earnings Call
WIXOM, Mich., May 05, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease ...
May 5, 2017
Rexahn Effects 1-for-10 Reverse Stock Split
ROCKVILLE, Md., May 05, 2017 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN) (“Rexahn” or the “Company”), a clinical stage biopharmaceutical company developing innovative, targeted ...
May 4, 2017
Gemphire to Host Key Opinion Leader Lunch on the Evolving NASH Landscape
LIVONIA, Mich., May 04, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, ...
May 4, 2017
Zogenix Provides Corporate Update and Reports First Quarter 2017 Financial Results
EMERYVILLE, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system ...
May 4, 2017
Mirati Therapeutics Reports First Quarter 2017 Financial Results
SAN DIEGO, May 4, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, reported financial results for the first quarter 2017 ...
May 4, 2017
TiGenix Cx601 positive long-term results to be presented at Digestive Disease Week
Leuven (BELGIUM) - May 4, 2017, 07:00h CEST - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory ...
May 4, 2017
Addex ADX71441 Preclinical Results for Treatment of Alcohol Use Disorder Published in Journal of Psychopharmacology
Geneva, Switzerland, 4 May 2017 - Addex Therapeutics (ADXN.SW) announced today that the results of a preclinical study evaluating ADX71441 in animal models of alcohol use ...
May 4, 2017
SciClone Pharmaceuticals To Report First Quarter 2017 Financial Results On May 10, 2017
FOSTER CITY, Calif., May 4, 2017 /PRNewswire/ -- SciClone Pharmaceuticals, Inc. (SCLN) today announced that it plans to report financial results for the first quarter ...
May 4, 2017
BioLife Solutions to Report First Quarter 2017 Financial Results and Provide Business Update on May 11, 2017
BOTHELL, Wash., May 4, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storageand cryopreservation freeze media ...
May 4, 2017
Paratek Pharmaceuticals, Inc. Reports First Quarter 2017 Financial Results and Provides Clinical Update
BOSTON, May 04, 2017 (GLOBE NEWSWIRE) --  Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
May 4, 2017
Evogene Files Annual Report for the Year Ended December 31, 2016
REHOVOT, Israel, May 04, 2017 (GLOBE NEWSWIRE) -- Evogene Ltd. (EVGN) (EVGN), a leading company for the improvement of crop productivity and economics for food, feed ...
May 4, 2017
Neovacs to Present Clinical Development Update On IFNα Kinoid in Dermatomyositis
PARIS and BOSTON, May 04, 2017 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV), a leader in active immunotherapies for the treatment of autoimmune diseases, today announced ...
May 4, 2017
Eiger BioPharmaceuticals to Host Key Opinion Leader Event Addressing Need for Novel Mechanisms in the Treatment of Pulmonary Arterial Hypertension (PAH) on May 10th in New York City
PALO ALTO, Calif., May 4, 2017 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, will host ...
May 4, 2017
CymaBay to Report First Quarter 2017 Financial Results on Thursday, May 11
NEWARK, Calif., May 04, 2017 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for specialty and orphan diseases ...
May 4, 2017
Minerva Neurosciences Reports First Quarter 2017 Financial Results and Business Updates
WALTHAM, Mass., May 04, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central ...
May 4, 2017
Rockwell Medical Mails Letter to Shareholders Profiling Independent Director Nominee David Domzalski
WIXOM, Mich., May 04, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI) today mailed a letter to its shareholders in connection with the Company's upcoming ...
May 4, 2017
Onconova Therapeutics, Inc. to Provide Corporate Update and First Quarter 2017 Financial Results
NEWTOWN, Pa., May 04, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products ...
Page 133 of 134